Contract notice: underwriting insurance contracts for the sivom de l~artois reference number: 06/2019 Underwriting insurance contracts for the sivom de l~artois This contract is divided into lots: yes it is [...]
Company restructuring/company reorganization and Company organization
Contract notice: Restructuration de l'ENIL BIO Poligny (39). This contract is divided into lots: Yes time limit for receipt of tenders or requests to participate: Date: 24/07/2019local time: 12:00 general [...]
Contract notice: 18s0106 requalification boulevard de l~atlantique - development works - territory of trignac and saint-nazaire Terrassement voirie sanitation - atlantic sector. This contract is divided into lots: yes Time [...]
Contract notice: maintenance work on the buildings of the communaut de l~agglomration havraise Masonry multi-attribute market. This contract is divided into lots: yes Time limit for receipt of tenders or [...]
Orbai AM, Holland R, Leung YY, Tillett W, Goel N, Christensen R, McHugh N, Gossec L, de Wit M, Højgaard P, Coates LC, Mease PJ, Birt J, Fallon L, FitzGerald O, Ogdie A, Shea B, Strand V, Duffin KC, Tugwell P, Beaton D, and Gladman DD
The Journal Of Rheumatology [J Rheumatol] 2019 Aug; Vol. 46 (8), pp. 990-995. Date of Electronic Publication: 2018 Dec 15.
Objective: The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and Outcome Measures in Rheumatology (OMERACT) psoriatic arthritis (PsA) working group is developing a Core Outcome Measurement Set for PsA clinical trials [randomized controlled trials (RCT) and longitudinal observational studies (LOS)] using the OMERACT Filter 2.1 instrument selection algorithm. Our objective was to assess the Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) for the measurement of the core domain PsA-specific health-related quality of life (HRQOL). Methods: PsAID12 measurement property evidence gathered in a systematic literature review, and additional analyses conducted in LOS, were used to inform a consensus process. Analyses that had not been published were independently reviewed by the OMERACT technical advisory group. Data and process were presented, discussed in breakout groups, and voted on at the OMERACT conference (Terrigal, Australia, May 2018). Results: PsAID12 fulfilled the green (good to go) OMERACT standards for domain match, feasibility, reliability, and construct/longitudinal construct validity. Discrimination and thresholds of meaning were amber (caution but good enough to go forward). The overall working group recommendation was amber/provisional endorsement of PsAID12 for measuring PsA-specific HRQOL in RCT and LOS. Of 96 participants who voted at the PsA OMERACT workshop, 87.5% (84) voted "yes" to endorse this recommendation; 14 of the 96 were patient research partners (PRP) and 93% of them (13) voted "yes"; 82 participants were not PRP and 87% of them (71) voted "yes." Conclusion: At OMERACT 2018, PsAID12 was the first patient-reported outcome measure provisionally endorsed as a core outcome measure for disease-specific HRQOL in PsA clinical trials. PsAID12 discrimination and improvement thresholds will be studied in future RCT.
de Paula Amorim L, Senna MIB, Alencar GP, Rodrigues LG, de Paula JS, and Ferreira RC
BMC Oral Health [BMC Oral Health] 2019 Oct 15; Vol. 19 (1), pp. 221. Date of Electronic Publication: 2019 Oct 15.
Following publication of the original article , the authors have reported that there is an error in Table 2 - Distribution of users concerning satisfaction with oral health services: the categories 'No' and 'Yes' should swap places.
Contract notice:electronic telecommunications for the university of pau and the pays de l~adour This market is divided into lots: yes Deadline for receipt of tenders or requests to participate: september [...]
Hsueh L, Peña JM, Hirsh AT, de Groot M, and Stewart JC
The Diabetes Educator [Diabetes Educ] 2019 Dec; Vol. 45 (6), pp. 642-651. Date of Electronic Publication: 2019 Sep 06.
Purpose: The purpose of the study was to examine associations of immigrant and racial/ethnic status with diabetes risk perception among a population-based sample of US adults without diabetes. Racial/ethnic minorities are at increased risk of developing diabetes. Emerging research shows that immigrant (foreign born) individuals are also at increased risk, but less is understood about risk perception in this group. Methods: Respondents were 11,569 adults from the NHANES (2011-2016; National Health and Nutrition Examination Survey) reporting no diabetes or prediabetes. Immigrant status was coded as foreign born or US born and analyses used NHANES racial/ethnic categories: white, black, Mexican American, other Hispanic, Asian, and other/multiracial. Immigrant status and variables comparing each minority group with whites were simultaneously entered into models predicting risk perception (yes/no), adjusting for demographic and diabetes risk factors. Results: Being foreign born was associated with decreased odds of perceived risk, while being Mexican American, Asian, and other/multiracial were associated with increased odds of perceived risk. Discussion: Foreign-born adults are less likely than US-born adults to report perceived risk for diabetes. Lower diabetes risk perception among immigrants could result in poorer preventative behaviors and later diabetes detection.
Sethunath V, Hu H, De Angelis C, Veeraraghavan J, Qin L, Wang N, Simon LM, Wang T, Fu X, Nardone A, Pereira R, Nanda S, Griffith OL, Tsimelzon A, Shaw C, Chamness GC, Reis-Filho JS, Weigelt B, Heiser LM, Hilsenbeck SG, Huang S, Rimawi MF, Gray JW, Osborne CK, and Schiff R
Molecular Cancer Research: MCR [Mol Cancer Res] 2019 Nov; Vol. 17 (11), pp. 2318-2330. Date of Electronic Publication: 2019 Aug 16.
Brouns B, Meesters JJL, Wentink MM, de Kloet AJ, Arwert HJ, Boyce LW, Vliet Vlieland TPM, and van Bodegom-Vos L
Journal Of Rehabilitation Medicine [J Rehabil Med] 2019 Oct 04; Vol. 51 (9), pp. 665-674.
Objective: Despite the increasing availability of eRehabilitation, its use remains limited. The aim of this study was to assess factors associated with willingness to use eRehabilitation. Design: Cross-sectional survey. Subjects: Stroke patients, informal caregivers, health-care professionals. Methods: The survey included personal characteristics, willingness to use eRehabilitation (yes/no) and barri-ers/facilitators influencing this willingness (4-point scale). Barriers/facilitators were merged into factors. The association between these factors and willingness to use eRehabilitation was assessed using logistic regression analyses. Results: Overall, 125 patients, 43 informal caregivers and 105 healthcare professionals participated in the study. Willingness to use eRehabilitation was positively influenced by perceived patient benefits (e.g. reduced travel time, increased motivation, better outcomes), among patients (odds ratio (OR) 2.68; 95% confidence interval (95% CI) 1.34-5.33), informal caregivers (OR 8.98; 95% CI 1.70-47.33) and healthcare professionals (OR 6.25; 95% CI 1.17-10.48). Insufficient knowledge decreased willingness to use eRehabilitation among pa-tients (OR 0.36, 95% CI 0.17-0.74). Limitations of the study include low response rates and possible response bias. Conclusion: Differences were found between patients/informal caregivers and healthcare professionals. Ho-wever, for both groups, perceived benefits of the use of eRehabilitation facilitated willingness to use eRehabili-tation. Further research is needed to determine the benefits of such programs, and inform all users about the potential benefits, and how to use eRehabilitation.